Jasper A J Smits Selected Research

Cycloserine (Seromycin)

1/2020	Enhancing panic and smoking reduction treatment with D-Cycloserine: A pilot randomized clinical trial.
1/2020	Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
12/2019	Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
1/2019	Effect of d-cycloserine on fear extinction training in adults with social anxiety disorder.
1/2017	D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
8/2015	Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
7/2015	Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
1/2014	Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
12/2013	D-cycloserine augmentation of cognitive behavioral group therapy of social anxiety disorder: prognostic and prescriptive variables.
11/2013	Sleep quality predicts treatment outcome in CBT for social anxiety disorder.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jasper A J Smits Research Topics

Disease

16	Anxiety Disorders (Anxiety Disorder) 11/2021 - 01/2008
11	Social Phobia 01/2020 - 03/2006
10	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019 - 09/2003
7	Panic Disorder (Panic Attack) 01/2020 - 09/2004
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 09/2020 - 04/2016
2	Mental Disorders (Mental Disorder) 01/2019 - 11/2010
2	Obesity 06/2016 - 11/2010
2	Phobic Disorders (Phobia) 06/2013 - 03/2006
2	Mood Disorders (Mood Disorder) 04/2013 - 11/2010
2	Major Depressive Disorder (Major Depressive Disorders) 01/2012 - 11/2010
1	Acute Pain 06/2019
1	Pain (Aches) 06/2019
1	Chronic Pain 06/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Metabolic Diseases (Metabolic Disease) 06/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Type 2 Diabetes Mellitus (MODY) 01/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2011
1	Psychotic Disorders (Schizoaffective Disorder) 01/2011
1	Antisocial Personality Disorder (Antisocial Personality) 01/2011
1	Agoraphobia 11/2010
1	Mania (Manias) 11/2010
1	Substance-Related Disorders (Drug Abuse) 09/2007

Drug/Important Bio-Agent (IBA)

16	Cycloserine (Seromycin)FDA Link 01/2020 - 03/2006
6	Nicotine FDA Link 09/2020 - 01/2013
4	Yohimbine (Yocon)IBA 01/2018 - 11/2013
3	Antidepressive Agents (Antidepressants)IBA 01/2017 - 11/2010
2	SmokeIBA 11/2021 - 02/2011
2	Pharmaceutical PreparationsIBA 01/2018 - 01/2011
2	Nootropic Agents (Nootropics)IBA 07/2015 - 08/2011
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015 - 01/2012
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 07/2013 - 03/2006
2	Anti-Anxiety Agents (Anxiolytics)IBA 04/2013 - 11/2010
1	Analgesics (Analgesic Drugs)IBA 06/2019
1	Menthol FDA Link 06/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2019
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2016
1	D 53IBA 06/2014
1	alpha-2 Adrenergic ReceptorsIBA 11/2013
1	Therapeutic UsesIBA 04/2013
1	N- methyl- N- (6- methoxy- 1- phenyl- 1,2,3,4- tetrahydronaphthalen- 2- ylmethyl)aminomethylcarboxylic acidIBA 05/2012
1	N-Methylaspartate (NMDA)IBA 05/2012
1	Glycine Plasma Membrane Transport ProteinsIBA 05/2012
1	Glutamate Receptors (Glutamate Receptor)IBA 05/2012
1	Carbon DioxideIBA 03/2012
1	Hypnotics and Sedatives (Sedatives)IBA 11/2010
1	Antipsychotic Agents (Antipsychotics)IBA 11/2010
1	Cocaine (Cocaine HCl)IBA 09/2007
1	Paroxetine (Paxil)FDA LinkGeneric 09/2004
1	Clonazepam (Rivotril)FDA LinkGeneric 09/2004
1	Dopamine (Intropin)FDA LinkGeneric 09/2003

Therapy/Procedure

4	Therapeutics 01/2019 - 11/2013
4	Drug Therapy (Chemotherapy) 11/2014 - 09/2004
1	Secondary Prevention 01/2012